Reducing leukocyte trafficking preserves hepatic function after sepsis

Journal of Trauma - Injury, Infection and Critical Care

Volumn 69, Issue 2, 2010, Pages 360-366

  Huynh, Toan ^a   Nguyen, Nhat ^b   Keller, Steven ^a   Moore, Cathy ^a   Shin, Min C ^a   McKillop, Iain H ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

^b University of North Carolina at Charlotte   (United States)

Author keywords

Cell trafficking; Leukocytes; Liver; Microcirculation; Sepsis

Indexed keywords

ACTIVATED PROTEIN C; ASPARTATE AMINOTRANSFERASE; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; SODIUM CHLORIDE; AMINOTRANSFERASE; CYTOKINE; PROTEIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; CELL MOTION; CONTROLLED STUDY; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER INJURY; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SEPSIS; ANALYSIS OF VARIANCE; ANIMAL; CELL ADHESION; COMPARATIVE STUDY; COMPLICATION; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; LIVER DISEASES; LIVER FUNCTION TEST; METABOLISM; MORTALITY; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; SURVIVAL RATE;

ANALYSIS OF VARIANCE; ANIMALS; CELL ADHESION; CELL MOVEMENT; CYTOKINES; DISEASE MODELS, ANIMAL; LEUKOCYTES; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TRANSAMINASES;

EID: 85052488837     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e3181e65133     Document Type: Article

References (31)

1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;26:296-327.
2. Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-353.
3. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358:111-124.
4. Remick DG. Pathophysiology of sepsis. Am J Pathol. 2007;170:1435-1444.
5. Deans KJ, Haley M, Natanson C, Eichacker PQ, Minneci PC. Novel therapies for sepsis: a review. J Trauma. 2005;58:867-876.
6. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-150.
7. Esmon CT, Taylor FB Jr, Snow TR. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost. 1991;66:160-165.
8. Yan SB, Grinnell BW. Recombinant human protein C, protein S, and thrombomodulin as antithrombotics. Perspect Drug Discovery Des. 1993;1:503-520.
9. Stouthard JM, Levi M, Hack CE, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost. 1996;76:738-742.
10. Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood. 1988;72:128-133.
11. Esmon CT. The protein C anticoagulant pathway. Arterioscler Thromb. 1992;12:135-145.
12. Kamoun WS, Shin MC, Keller S, Karaa A, Huynh T, Clemens MG. Induction of biphasic changes in perfusion heterogeneity of rat liver after sequential stress in vivo. Shock. 2005;24:324-331.
13. Keller S, Clemens MG, Huynh T. Activated protein C protects hepatic microcirculation and preserves hepatocellular function after trauma and sepsis. J Surg Res. 2006;130:212-213.
14. Matthay MA. Severe sepsis-a new treatment with both anticoagulant and anti-inflammatory properties. N Engl J Med. 2001;344:759-762.
15. Yuan Q, Liu YY, Sun K, et al. Improving effect of pretreatment with Yiqifumai on LPS-induced microcirculatory disturbance in rat mesentery. Shock. 2009;32:310-316.
16. Draisma A, Bemelmans R, van der Hoeven JG, et al. Microcirculation and vascular reactivity during endotoxin tolerance in humans. Shock. 2009;31:581-585.
17. Ince C. The microcirculation is the motor of sepsis. Crit Care. 2005;9: S13-S19.
18. Joyce DE, Gelbert L, Ciaccia A, DeHoff B, Grinnell BW. Gene expression profile of antithrombotic protein C defines new mechanisms modulating inflammation and apoptosis. J Biol Chem. 2001; 276:11199-11203.
19. Fisher CJ Jr, Yan SB. Protein C levels as a prognostic indicator of outcome in sepsis and related diseases. Crit Care Med. 2000;28(9 suppl):S49-S56.
20. Bernard GR, Vincent JL, Laterre PF, et al; Recombinant Human Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709.
21. Iba T, Kidokoro A, Fukunaga M, Nagakari K, Shirahama A, Ida Y. Activated protein C improves the visceral microcirculation by attenuating the leukocyte-endothelial interaction in rat lipopolysaccharide model. Crit Care Med. 2005;33:368-372.
22. Freund Y, Schapire R. A short introduction to boosting. J Japan Soc Artificial Intelligence. 1999;14:771-780.
23. Haralick RM, Shapiro LG. Computer and Robot Vision. Vol 1. Reading, MA: Addison-Wesley; 1992:28-48.
24. Brower RG, Matthey MA, Morris A, et al.; the ARDS Network. Ventilation with low tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
25. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345: 1368-1377.
26. Osuchowski MF, Connett J, Welch K, Granger J, Remick DG. Stratification is the key: inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med. 2009;37:1567-1573.
27. Joyce DE, Nelson DR, Grinnell BW. Leukocyte and endothelial cell interactions in sepsis: relevance of the protein C pathway. Crit Care Med. 2004;32(suppl):S280-S286.
28. Keller S, Paxian M, Ashburn JH, Clemens MG, Huynh T. Kupffer cell ablation improves hepatic microcirculation after trauma and sepsis. J Trauma. 2005;58:740-751. (Pubitemid 40592742)
29. Khandoga AG, Khandoga A, Anders HJ, Krombach F. Post-ischemic vascular permeability requires both TLR-2 and TLR-4, but only TLR-2 mediates the transendothelial migration of leukocytes. Shock. 2009;31:592-598.
30. Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multi-functional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19:91-104.
31. Riewald M, Petrovan R, Donner A, Mueller BM, Ruf W. Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science. 2002;296:1880-1882.